Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States

Corporate Breaking News

Home : Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States

Mar 05 2020	Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States
MISSISSAUGA, ON, March 4, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Dr. Reddy's Laboratories Inc. (DRL) has...


Source:https://www.prnewswire.com:443/news-releases/nuvo-pharmaceuticals-announces-at-risk-launch-of-generic-version-of-vimovo-in-the-united-states-301016786.html

Related News
» The Knowledge Group Has Scheduled a Live Webcast on Statistical Analysis to Prove Causation in Labor and Employment Litigation » Janssen składa wniosek o europejskie pozwolenie na dopuszczenie do obrotu leku ponesimod w leczeniu dorosłych z nawracającym stwardnieniem rozsianym